Long-term efficacy of lurasidone in antipsychotic-naive vs. antipsychotic-exposed adolescents with schizophrenia: Post-hoc analysis of a two year, open-label study

被引：0
|
作者：
Correll, C. [1 ,2 ]
Goldman, R. [3 ]
Tocco, M. [4 ]
Pikalov, A. [5 ]
Loebel, A. [4 ]
机构：
[1] Zucker Hillside Hosp, Hofstra Northwell Sch Med, Glen Oaks, NY USA
[2] Charite, Psychiat Mol Biol & Child & Adolescent Psychiat, Berlin, Germany
[3] Sunovion Pharmaceut Inc, Res & Dev, Marlborough, MA USA
[4] Sunovion Pharmaceut Inc, Med Affairs, Marlborough, MA USA
[5] Sunovion Pharmaceut Inc, Med Affairs, Ft Lee, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.157
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.102
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [41] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Ruediger B. Mueller
    Hendrik Schulze-Koops
    Daniel E. Furst
    Stanley B.  Cohen
    Kenneth Kwok
    Lisy Wang
    Tim Killeen
    Johannes von Kempis
    Clinical Rheumatology, 2022, 41 : 1045 - 1055
  • [42] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Mueller, Ruediger B.
    Schulze-Koops, Hendrik
    Furst, Daniel E.
    Cohen, Stanley B.
    Kwok, Kenneth
    Wang, Lisy
    Killeen, Tim
    von Kempis, Johannes
    CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1045 - 1055
  • [43] Long-term efficacy of ziprasidone in treatment-resistant schizophrenia: Results from the 1-year, open-label mozart extension study
    Sacchetti, E.
    Galluzzo, A.
    Romeo, F.
    Gorini, B.
    Rappard, F.
    EUROPEAN PSYCHIATRY, 2007, 22 : S165 - S165
  • [44] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    CNS DRUGS, 2017, 31 (07) : 625 - 638
  • [45] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    David R. Coghill
    Tobias Banaschewski
    Peter Nagy
    Isabel Hernández Otero
    César Soutullo
    Brian Yan
    Beatriz Caballero
    Alessandro Zuddas
    CNS Drugs, 2017, 31 : 625 - 638
  • [46] Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study
    Ochs-Ross, Rachel
    Wajs, Ewa
    Daly, EllaJ.
    Zhang, Yun
    Lane, Rosanne
    Lim, Pilar
    Drevets, Wayne C.
    Steffens, David C.
    Sanacora, Gerard
    Jamieson, Carol
    Hough, David
    Manji, Husseini
    Singh, Jaskaran B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (05): : 541 - 556
  • [47] Long-term efficacy and tolerability of brivaracetam in pediatric patients with focal-onset seizures and cognitive or learning comorbidities: Post hoc analysis of an open-label trial
    Bourikas, Dimitrios
    Koch, Juliane
    de la Loge, Christine
    Dimova, Svetlana
    Elmoufti, Sami
    Moseley, Brian
    Lagae, Lieven
    EPILEPSY RESEARCH, 2025, 209
  • [48] Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence
    Si, Tianmei
    Li, Nan
    Lu, Huafei
    Cai, Shangli
    Zhuo, Jianmin
    Correll, Christoph U.
    Zhang, Lili
    Feng, Yu
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (06) : 691 - 701
  • [49] LONG-TERM SAFETY AND EFFICACY OF BLONANSERIN ORAL TABLET (DSP-5423) IN ADOLESCENTS WITH SCHIZOPHRENIA: A 52-WEEK, MULTICENTER, OPEN-LABEL, EXTENSION STUDY
    Saito, Takuya
    Nakamura, Hiroshi
    Ishigooka, Jun
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S216 - S216
  • [50] Efficacy and Safety of Tofacitinib in an Open-Label, Long-Term Extension Study in Patients with Psoriatic Arthritis Who Received Adalimumab or Tofacitinib in a Phase 3 Randomized Controlled Study: A Post Hoc Analysis
    Gladman, Dafna
    Nash, Peter
    Mease, Philip J.
    FitzGerald, Oliver
    Masri, Karim R.
    Duench, Stephanie
    Jane Cadatal, Mary
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2798 - 2801
12345